Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ProPhase Labs, Inc. | v303307_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - ProPhase Labs, Inc. | v303307_ex32-1.htm |
| EX-23.1 - EXHIBIT 23.1 - ProPhase Labs, Inc. | v303307_ex23-1.htm |
| EX-32.2 - EXHIBIT 32.2 - ProPhase Labs, Inc. | v303307_ex32-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ProPhase Labs, Inc. | v303307_ex31-1.htm |
| EX-23.2 - EXHIBIT 23.2 - ProPhase Labs, Inc. | v303307_ex23-2.htm |
| EX-31.2 - EXHIBIT 31.2 - ProPhase Labs, Inc. | v303307_ex31-2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ProPhase Labs, Inc. | Financial_Report.xls |
EXHIBIT 21.1
SUBSIDIARIES OF PROPHASE LABS, INC.
| State or other | ||||||||
| Jurisdiction of | Ownership | |||||||
| Subsidiaries | Incorporation | Percentage | ||||||
| Pharmaloz Manufacturing Inc. | Delaware | 100 | % | |||||
| Phusion Laboratories, LLC | Delaware | 50 | % | |||||
| Quigley Pharma Inc. | Delaware | 100 | % | |||||
The above subsidiaries are included in the consolidated financial statements for the year ended December 31, 2011.